198 related articles for article (PubMed ID: 1628630)
21. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
22. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
23. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
[TBL] [Abstract][Full Text] [Related]
24. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-transcriptional controls.
Neale GA; Fitzgerald TJ; Goorha RM
Mol Immunol; 1992 Dec; 29(12):1457-66. PubMed ID: 1454064
[TBL] [Abstract][Full Text] [Related]
25. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
Oettinger MA; Schatz DG; Gorka C; Baltimore D
Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
[TBL] [Abstract][Full Text] [Related]
26. High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.
Möröy T; Fisher PE; Lee G; Achacoso P; Wiener F; Alt FW
J Exp Med; 1992 Feb; 175(2):313-22. PubMed ID: 1310099
[TBL] [Abstract][Full Text] [Related]
27. Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking.
Turka LA; Schatz DG; Oettinger MA; Chun JJ; Gorka C; Lee K; McCormack WT; Thompson CB
Science; 1991 Aug; 253(5021):778-81. PubMed ID: 1831564
[TBL] [Abstract][Full Text] [Related]
28. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
29. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice.
Spanopoulou E; Roman CA; Corcoran LM; Schlissel MS; Silver DP; Nemazee D; Nussenzweig MC; Shinton SA; Hardy RR; Baltimore D
Genes Dev; 1994 May; 8(9):1030-42. PubMed ID: 7926785
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice.
Jacobsen KA; Prasad VS; Sidman CL; Osmond DG
Blood; 1994 Oct; 84(8):2784-94. PubMed ID: 7522642
[TBL] [Abstract][Full Text] [Related]
31. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
[TBL] [Abstract][Full Text] [Related]
32. Secondary V(D)J rearrangements and B cell receptor-mediated down-regulation of recombination activating gene-2 expression in a murine B cell line.
Maës J; Caspi Y; Rougeon F; Haimovich J; Goodhardt M
J Immunol; 2000 Jul; 165(2):703-9. PubMed ID: 10878342
[TBL] [Abstract][Full Text] [Related]
33. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.
Han S; Zheng B; Schatz DG; Spanopoulou E; Kelsoe G
Science; 1996 Dec; 274(5295):2094-7. PubMed ID: 8953043
[TBL] [Abstract][Full Text] [Related]
34. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
35. Regulation of antigen receptor gene assembly in lymphocytes.
Oltz EM
Immunol Res; 2001; 23(2-3):121-33. PubMed ID: 11444378
[TBL] [Abstract][Full Text] [Related]
36. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
37. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
38. MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an E mu-myc transgene.
Algarra I; Silva S; Ljunggren HG
Eur J Cancer; 1993; 29A(2):238-41. PubMed ID: 8422288
[TBL] [Abstract][Full Text] [Related]
39. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
40. Antibody class switch recombinase activity is B cell stage specific and functions stochastically in the absence of 'targeted accessibility' control.
Ballantyne J; Henry DL; Marcu KB
Int Immunol; 1997 Jul; 9(7):963-74. PubMed ID: 9237105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
